• Yi-Hua Liao, Chia-Bao Chu, HuiChung-Yee RosalineCRDepartment of Dermatology, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan., Cheng-Yuan Li, Sheng-Yao Lin, Han-Chi Tseng, Yen-Jen Wang, Jennifer Wu, Wei-Wen Yu, and Sheau-Chiou Chao.
• Department of Dermatology, National Taiwan University Hospital, Taipei, Taiwan; College of Medicine, National Taiwan University, Taipei, Taiwan.
• J Formos Med Assoc. 2023 Dec 29.

AbstractHidradenitis suppurativa (HS) is a chronic inflammatory follicular disease characterized by painful, recurrent, inflamed lesions most commonly occurring in the axillary, inguinal, and anogenital regions. HS can inflict immense physical and psychological impact on patients who suffer from this distressing disease. Management of HS generally requires combining various medical and procedural treatment modalities; however, the disease is often recalcitrant to conventional treatments. In light of recent evidence supporting the effectiveness of biologic agents in the treatment of HS, the Taiwanese Dermatological Association established an expert panel of nine dermatologists to develop consensus statements aimed to provide up-to-date evidence-based guidance in optimizing HS patient management in Taiwan. The recommendations described in the statements were summarized in a management algorithm in terms of general care, topical treatment, systemic treatment, and procedural treatment.Copyright © 2023 Formosan Medical Association. Published by Elsevier B.V. All rights reserved.

5 keywords...

hide…